Page last updated: 2024-08-22

vidarabine and 2'-fluoro-2'-deoxyadenosine

vidarabine has been researched along with 2'-fluoro-2'-deoxyadenosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allerson, CR; Bennett, CF; Bera, S; Bhat, B; Bhat, N; Bosserman, MR; Brooks, J; Burlein, C; Carroll, SS; Cook, PD; Eldrup, AB; Getty, KL; MacCoss, M; McMasters, DR; Olsen, DB; Prakash, TP; Prhavc, M; Song, Q; Tomassini, JE; Xia, J1
An, SH; Au, A; Garza, G; Land, KM; Shokar, A; Tong, E; Wnuk, SF; Zayas, J1
Bacon, PE; Brown, NC; Carter, GL; Cory, JG; Montgomery, JA; Sato, A1
Cory, JG; Montgomery, JA; Sato, A1
Hulkkonen, J; Hurme, M; Kivekäs, I; Vilpo, J; Vilpo, L1

Other Studies

5 other study(ies) available for vidarabine and 2'-fluoro-2'-deoxyadenosine

ArticleYear
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.
    Journal of medicinal chemistry, 2004, Apr-22, Volume: 47, Issue:9

    Topics: Adenosine Deaminase; Hepacivirus; Hydrogen Bonding; Methylation; Molecular Conformation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Purines; Ribonucleosides; Ribose; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Viral Nonstructural Proteins

2004
S-Adenosylhomocysteine hydrolase of the protozoan parasite Trichomonas vaginalis: potent inhibitory activity of 9-(2-deoxy-2-fluoro-β,D-arabinofuranosyl)adenine.
    Bioorganic & medicinal chemistry letters, 2012, Jun-15, Volume: 22, Issue:12

    Topics: Adenosine; Adenosylhomocysteinase; Animals; Antiprotozoal Agents; Cell Culture Techniques; Cell Survival; CHO Cells; Cricetinae; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Metronidazole; Protozoan Proteins; Structure-Activity Relationship; Trichomonas vaginalis; Uridine

2012
The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
    Advances in enzyme regulation, 1985, Volume: 23

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Deoxyadenosines; Deoxyguanosine; Hydroxyurea; Isoquinolines; Leukemia L1210; Models, Biological; Nucleic Acid Synthesis Inhibitors; Phosphorylases; Pyrazoles; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thymidine; Vidarabine

1985
Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
    Cancer research, 1984, Volume: 44, Issue:8

    Topics: Animals; Cell Survival; Cytidine; Deferoxamine; Deoxyadenosines; Deoxycytidine; Drug Synergism; Hydroxyurea; Kinetics; Leukemia L1210; Mice; Pyrazoles; Vidarabine

1984
CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia.
    Leukemia research, 2002, Volume: 26, Issue:5

    Topics: Antineoplastic Agents; B7-1 Antigen; Deoxyadenosines; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine

2002